Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Alzinova AB (publ)

ALZ.ST

HealthcareSTOSE

SEK 0.4615

+SEK 0.002 (+0.44%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

ALZ.ST

1Y+0.0105 (+2.29%)

Candles, volume, SMA 20, and SMA 50

O 0.459H 0.497L 0.4425C 0.47Date Jun 10

ALZ.ST

SMA 20 SMA 50 Vol 381.75K

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Alzinova AB (publ) is a Swedish biotechnology company dedicated to advancing novel immunotherapies against Alzheimer's disease. Their primary investigational product, ALZ-101, is a vaccine specifically designed to target oligomers responsible for Alzheimer's. Additionally, they are developing ALZ-201, a monoclonal antibody aimed at neutralizing harmful amyloid-beta (Aß) oligomers. Established in 2011, the company's operations are headquartered in Mölndal, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$48.19M

Volume?381.72K

Avg Volume?1.04M

52w RangeSEK 0.382 - SEK 2.28

Beta?0.76

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide